Efficacy and safety of Tripterygium wilfordii glycosides tablets combined with Western medicine for patients with rheumatic immune diseases

doi:10.12998/wjcc.v13.i6.95513

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (424)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

HTML

211

Figures (1-4)

Tables (1-3)

Sum=326

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=80

Feb 26, 2025 (publication date) through Jan 4, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Clin Cases. Feb 26, 2025; 13(6): 95513
Published online Feb 26, 2025. doi: 10.12998/wjcc.v13.i6.95513

Open in New Tab Full Size Figure Download Figure

Figure 1 Flow diagram of study inclusion process. CNKI: China National Knowledge Infrastructure.

Open in New Tab Full Size Figure Download Figure

Figure 2 Risk of bias graph.

Open in New Tab Full Size Figure Download Figure

Figure 3 Forest plot of total efficacy. RR: Relative risk.

Open in New Tab Full Size Figure Download Figure

Figure 4 Forest plot of visual analog scale score.

Citation: Shu H, Chen XY, Zhao J, Li P, Sun Z. Efficacy and safety of Tripterygium wilfordii glycosides tablets combined with Western medicine for patients with rheumatic immune diseases. World J Clin Cases 2025; 13(6): 95513
URL: https://www.wjgnet.com/2307-8960/full/v13/i6/95513.htm
DOI: https://dx.doi.org/10.12998/wjcc.v13.i6.95513